HomeStrategyA $435 Million Bet on ‘Reversing Aging’ Strategy A $435 Million Bet on ‘Reversing Aging’ Strategy June 7, 2026 0 293 FacebookXPinterestWhatsApp Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver. FacebookXPinterestWhatsApp Cody Previous articleDell sharpens data protection strategy as AI reshapes cyber resilienceNext articleLayoffs don’t have to feel inhumane RELATED ARTICLES Strategy Why Your ChatGPT Traffic Dropped in October (and Why It Might Be a Reporting Trap) Strategy Voters might finally agree on something: They don’t want Matthew McConaughey in politics Strategy A photo of your face could reveal how likely you are to survive cancer, a new study finds Strategy Job market nightmare: This hiring manager’s post is going viral for revealing a flawed recruiting tactic Must Read When It’s Time to Look for a New Nonprofit Marketing Agency Business AI infrastructure management software startup ASI hits $3B valuation after raising $325M in funding Tech Mastercard Black Card Review – $300 in Credits Can Cut the $699 Fee to $399 Finance Mastercard Gold Card Review – The $1,199 Fee Buys Prestige More Than Rewards Finance Mastercard Titanium Card Review – $299 Buys Lounge Access, Not Better Rewards Finance